Works matching IS 19116470 AND DT 2014 AND VI 8 AND IP 11/12


Results: 17
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Evaluation of second-line and subsequent targeted therapies in metastatic renal cell cancer (mRCC) patients treated with first-line cediranib.

    Published in:
    Canadian Urological Association Journal, 2014, v. 8, n. 11/12, p. 398, doi. 10.5489/cuaj.2426
    By:
    • Richter, Suzanne;
    • Jo-An Seah;
    • Pond, Gregory R.;
    • Gan, Hui K.;
    • Mackenzie, Mary J.;
    • Hotte, Sebastien J.;
    • Mukherjee, Som D.;
    • Murray, Nevin;
    • Kollmannsberger, Christian;
    • Heng, Daniel;
    • Haider, Masoom A.;
    • Halford, Robert;
    • Ivy, S. Percy;
    • Moore, Malcolm J.;
    • Sridhar, Srikala S.
    Publication type:
    Article
    12
    13
    14
    15

    Faire entendre nos voix.

    Published in:
    Canadian Urological Association Journal, 2014, v. 8, n. 11/12, p. 392, doi. 10.5489/cuaj.2584
    By:
    • Oake, J. Stuart
    Publication type:
    Article
    16

    Making our voices heard.

    Published in:
    Canadian Urological Association Journal, 2014, v. 8, n. 11/12, p. 391, doi. 10.5489/cuaj.2579
    By:
    • Oake, J. Stuart
    Publication type:
    Article
    17